EDWARDS LIFESCIENCES CORPORATION (EW) FY2024 Annual Statement of Cash Flows

Income StatementCash FlowBalance Sheet

Statement of Cash Flows

2024-01-01 to 2024-12-31

Swipe to see the full flow
EDWARDS LIFESCIENCES CORPORATION cash flow reconciliation, Jan 1, 2024 through Dec 31, 2024One connected Sankey reconciles operating, investing and financing net cash flows through a shared cash pool, from beginning cash to ending cash. Ribbons flow left to right on one dollar scale. Activity totals are dark gray; beginning and ending cash are blue. Cash basis for beginning and ending balances and net cash change: Cash, cash equivalents, and restricted cash. Intermediate calculation bars are lighter gray. Net income is green for profit and red for loss. Identified asset purchases, sales and maturities are blue in either cash direction. Purple identifies capital transactions such as borrowing, repayments, share issuance and dividends. Free cash flow is a separate comparison, not an added cash flow. Read chart description and values below for full signed amounts, including zero items.Net income → Net cash from operating activities: $542,300,000.00Net income → Operating adjustments reconciliation: $3,627,400,000.00Stock-based compensation (Notes 2 and 16) → Operating adjustments reconciliation: $162,300,000.00Depreciation and amortization → Operating adjustments reconciliation: $155,200,000.00Accounts and other receivables, net → Operating adjustments reconciliation: $121,200,000.00Accounts payable and accrued liabilities → Operating adjustments reconciliation: $89,500,000.00Non-cash operating lease cost → Operating adjustments reconciliation: $27,800,000.00Prepaid expenses and other current assets → Operating adjustments reconciliation: $22,700,000.00Other → Operating adjustments reconciliation: $18,400,000.00Long-term prepaid royalties (Note 3) → Operating adjustments reconciliation: $8,300,000.00Operating adjustments reconciliation → Gain on sale of product group (Note 5): $3,348,200,000.00Operating adjustments reconciliation → Deferred income taxes: $323,400,000.00Operating adjustments reconciliation → Inventories: $256,100,000.00Operating adjustments reconciliation → Income taxes: $186,700,000.00Operating adjustments reconciliation → Gain on remeasurement of previously held equity interest upon acquisition (Note 10): $55,000,000.00Operating adjustments reconciliation → Intellectual property agreement accrual: $36,800,000.00Operating adjustments reconciliation → Other: $21,400,000.00Operating adjustments reconciliation → (Gain) loss on investments, net: $5,200,000.00Proceeds from sale of product group → investing reconciliation: $3,927,400,000.00Proceeds from sales and maturities of available-for-sale investments (Note 8) → investing reconciliation: $800,100,000.00Proceeds from sales and maturities of held-to-maturity investments (Note 8) → investing reconciliation: $57,500,000.00investing reconciliation → Net cash from investing activities: $2,312,900,000.00investing reconciliation → Business combinations, net of cash (Note 10): $1,061,800,000.00investing reconciliation → Purchases of available-for-sale investments (Note 8): $899,900,000.00investing reconciliation → Capital expenditures: $252,400,000.00investing reconciliation → Other: $72,900,000.00investing reconciliation → Issuances of notes receivable: $63,000,000.00investing reconciliation → Payments for acquisition options (Note 9): $46,200,000.00investing reconciliation → Purchases of held-to-maturity investments (Note 8): $45,900,000.00investing reconciliation → Investments in intangible assets: $30,000,000.00Net cash used in financing activities → financing reconciliation: $983,000,000.00Proceeds from stock plans → financing reconciliation: $179,500,000.00financing reconciliation → Purchases of treasury stock: $1,159,400,000.00financing reconciliation → Other: $3,100,000.00Exchange-rate effect → Cash sources and uses: $38,600,000.00Beginning cash: Cash, cash equivalents, and restricted cash → Cash sources and uses: $1,148,000,000.00Net cash from operating activities → Cash sources and uses: $542,300,000.00Net cash from investing activities → Cash sources and uses: $2,312,900,000.00Cash sources and uses → Ending cash: Cash, cash equivalents, and restricted cash: $3,058,800,000.00Cash sources and uses → Net cash used in financing activities: $983,000,000.00Impairment charges (Note 4): $0.00Accounts and other receivables, net: $121,200,000.00Accounts & other receivables+$121.20 MStock-based compensation (Notes 2 and 16): $162,300,000.00Stock-based compensation+$162.30 MDeferred income taxes: -$323,400,000.00Deferred tax balances−$323.40 MNon-cash operating lease cost: $27,800,000.00Operating lease amortization+$27.80 MPrepaid expenses and other current assets: $22,700,000.00Prepaid & other assets+$22.70 MIncome taxes: -$186,700,000.00Income taxes payable−$186.70 MDepreciation and amortization: $155,200,000.00Depreciation & amortization+$155.20 MInventories: -$256,100,000.00Inventories−$256.10 MOther: $18,400,000.00Other non-cash items+$18.40 MIntellectual property agreement accrual: -$36,800,000.00Intellectual property accrual−$36.80 MOther: -$21,400,000.00Other working capital, net−$21.40 MAccounts payable and accrued liabilities: $89,500,000.00Payables & accrued liabilities+$89.50 MChange in fair value of contingent consideration liabilities (Note 13): $0.00Net income: $4,169,700,000.00Net income+$4.17 B(Gain) loss on investments, net: -$5,200,000.00Investment gain & loss−$5.20 MLong-term prepaid royalties (Note 3): $8,300,000.00Long-term prepaid royalties (Note 3)+$8.30 MGain on sale of product group (Note 5): -$3,348,200,000.00Business sale gain & loss−$3.35 BGain on remeasurement of previously held equity interest upon acquisition (Note 10): -$55,000,000.00Stake remeasurement gain & loss−$55.00 MNet cash from operating activities: $542,300,000.00Operating cash+$542.30 MOperating adjustments reconciliation: $4,232,800,000.00Other: -$3,100,000.00Other financing, net−$3.10 MPurchases of treasury stock: -$1,159,400,000.00Common stock repurchases−$1.16 BProceeds from stock plans: $179,500,000.00Stock plan proceeds+$179.50 MNet cash used in financing activities: -$983,000,000.00. Cash required to fund net payments.Financing cash−$983.00 Mfinancing reconciliation: $1,162,500,000.00Issuances of notes receivable: -$63,000,000.00Issuances of notes receivable−$63.00 MProceeds from sales and maturities of held-to-maturity investments (Note 8): $57,500,000.00HTM sales & maturities+$57.50 MCollections of notes receivable: $0.00Purchases of available-for-sale investments (Note 8): -$899,900,000.00AFS securities purchases−$899.90 MProceeds from sales and maturities of available-for-sale investments (Note 8): $800,100,000.00AFS securities proceeds+$800.10 MPurchases of held-to-maturity investments (Note 8): -$45,900,000.00HTM securities purchases−$45.90 MInvestments in intangible assets: -$30,000,000.00Intangible asset purchases−$30.00 MCapital expenditures: -$252,400,000.00PP&E purchases−$252.40 MPayments for acquisition options (Note 9): -$46,200,000.00Payments for acquisition options (Note 9)−$46.20 MOther: -$72,900,000.00Other investing, net−$72.90 MBusiness combinations, net of cash (Note 10): -$1,061,800,000.00Acquisitions, net of cash−$1.06 BProceeds from sale of product group: $3,927,400,000.00Business sales+$3.93 BNet cash from investing activities: $2,312,900,000.00Investing cash+$2.31 Binvesting reconciliation: $4,785,000,000.00Cash sources and uses: $4,041,800,000.00Beginning cash: Cash, cash equivalents, and restricted cash: $1,148,000,000.00Beginning cash$1.15 BEnding cash: Cash, cash equivalents, and restricted cash: $3,058,800,000.00Ending cash$3.06 BExchange-rate effect: $38,600,000.00FX effect+$38.60 MCASH RECONCILIATIONOperatingflowsInvestingflowsFinancingflowsFree cash flow$289.90 MOperating cash − cash spent on PP&ECash flow / Net income0.13×Operating cash flow ÷ net incomeNet cash change+$1.91 BEnding cash − beginning cash
Chart details

EDWARDS LIFESCIENCES CORPORATION cash flow reconciliation, Jan 1, 2024 through Dec 31, 2024

Cash flows for Jan 1, 2024 through Dec 31, 2024. Cash basis: Cash, cash equivalents, and restricted cash. Beginning cash: Dec 31, 2023. Ending cash: Dec 31, 2024. Beginning and ending cash are dated balances. Positive cash flows add cash; negative cash flows reduce it.

Beginning cash on Dec 31, 2023
1,148,000,000 US dollars. Beginning cash: Cash, cash equivalents, and restricted cash
Operating activities
542,300,000 US dollars. Net cash provided.
Impairment charges (Note 4)
0 US dollars
Accounts and other receivables, net
121,200,000 US dollars
Stock-based compensation (Notes 2 and 16)
162,300,000 US dollars
Deferred income taxes
negative 323,400,000 US dollars
Non-cash operating lease cost
27,800,000 US dollars
Prepaid expenses and other current assets
22,700,000 US dollars
Income taxes
negative 186,700,000 US dollars
Depreciation and amortization
155,200,000 US dollars
Inventories
negative 256,100,000 US dollars
Other
18,400,000 US dollars
Intellectual property agreement accrual
negative 36,800,000 US dollars
Other
negative 21,400,000 US dollars
Accounts payable and accrued liabilities
89,500,000 US dollars
Change in fair value of contingent consideration liabilities (Note 13)
0 US dollars
Net income
4,169,700,000 US dollars
(Gain) loss on investments, net
negative 5,200,000 US dollars
Long-term prepaid royalties (Note 3)
8,300,000 US dollars
Gain on sale of product group (Note 5)
negative 3,348,200,000 US dollars
Gain on remeasurement of previously held equity interest upon acquisition (Note 10)
negative 55,000,000 US dollars
Investing activities
2,312,900,000 US dollars. Net cash provided.
Issuances of notes receivable
negative 63,000,000 US dollars
Proceeds from sales and maturities of held-to-maturity investments (Note 8)
57,500,000 US dollars
Collections of notes receivable
0 US dollars
Purchases of available-for-sale investments (Note 8)
negative 899,900,000 US dollars
Proceeds from sales and maturities of available-for-sale investments (Note 8)
800,100,000 US dollars
Purchases of held-to-maturity investments (Note 8)
negative 45,900,000 US dollars
Investments in intangible assets
negative 30,000,000 US dollars
Capital expenditures
negative 252,400,000 US dollars
Payments for acquisition options (Note 9)
negative 46,200,000 US dollars
Other
negative 72,900,000 US dollars
Business combinations, net of cash (Note 10)
negative 1,061,800,000 US dollars
Proceeds from sale of product group
3,927,400,000 US dollars
Financing activities
negative 983,000,000 US dollars. Net cash used.
Other
negative 3,100,000 US dollars
Purchases of treasury stock
negative 1,159,400,000 US dollars
Proceeds from stock plans
179,500,000 US dollars
Operating adjustment reconciliation
4,232,800,000 US dollars. Intermediate calculation joining the operating reconciliation branches. Its gross amount includes any portion of net income routed through this junction. It is not an additional cash source or use.
financing gross reconciliation
1,162,500,000 US dollars. Gross amount at the activity's junction before offsetting its receipts and deductions. It is not an additional cash source or use.
investing gross reconciliation
4,785,000,000 US dollars. Gross amount at the activity's junction before offsetting its receipts and deductions. It is not an additional cash source or use.
Exchange-rate effect
38,600,000 US dollars
Ending cash on Dec 31, 2024
3,058,800,000 US dollars. Ending cash: Cash, cash equivalents, and restricted cash
Cash sources and uses
4,041,800,000 US dollars. Opening cash plus net sources, equal to net uses plus ending cash.
Net cash change
1,910,800,000 US dollars. Ending cash minus beginning cash.
Cash flow / Net income
0.13×. Operating cash flow divided by reconciliation net income for the same period. Black from 0.90× through 1.10×; green above 1.10×; red below 0.90×. Color uses the unrounded ratio.
Operating cash flow
542,300,000 US dollars. Operating cash flow used in the free cash flow calculation.
Cash purchases of property, plant and equipment
252,400,000 US dollars. These cash purchases are already included in investing activities above.
Free cash flow
289,900,000 US dollars. A supplemental measure; finance-lease payments are excluded from this definition.

Chart connections

  • Beginning cash plus operating, investing and financing cash flows plus the exchange-rate effect equals ending cash. Negative amounts reduce cash.
  • Financing contributions meet at a reconciliation junction before connecting to the net cash total.
  • Investing contributions meet at a reconciliation junction before connecting to the net cash total.
  • Operating reconciliation adjustments are not all independent cash receipts.
  • Net income exceeds operating cash. The diagram allocates $542.30M of net income directly to operating cash and $3.63B to the adjustment junction, where it combines with other additions to reconcile deductions. This is an accounting presentation, not a tracing of cash receipts.
  • Each activity has one net cash bar connected to the shared cash pool. Positive activity totals enter the pool; negative activity totals leave the pool to fund that activity's net payments. The central pool does not assign a particular funding source to a particular payment.
  • The intermediate calculation bars include both sides of the displayed activity breakdowns; they are not additional cash flows.
  • Operating cash flow minus cash purchases of property, plant and equipment equals free cash flow: 542,300,000 US dollars minus 252,400,000 US dollars equals 289,900,000 US dollars.
EDWARDS LIFESCIENCES CORPORATION (EW) FY2024 Annual Statement of Cash Flows Sankey chart
Free to share unchanged, with credit to Plicit.ai · CC BY-NC-ND 4.0Download PNG

Newsletter

Get the teardowns by email

Subscribe if you want the public-company teardowns in your inbox when they're released.

Product waitlist

Health Check and Teardown for your own company

A health check uncovers insights of your private books, not a public ticker. Join this list to get notified as soon as we go-live!